808 filings
Page 18 of 41
8-K
ztydz
9 Dec 14
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
12:00am
8-K
zmyjlxvgm0om ieua
14 Nov 14
Departure of Directors or Certain Officers
12:00am
8-K
82b6nc q2k
30 Oct 14
Other Events
12:00am
8-K
5aid32a5zytypre4ejq
17 Oct 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ll9mcv fu1jp
9 Sep 14
Peregrine Pharmaceuticals Reports first Quarter Fiscal Year 2015 Financial Results and Recent Developments
12:00am
8-K
il7hoj8
8 Sep 14
Peregrine PHARMACEUTICALS DECLARES QUARTERLY DIVIDEND on ITS Series E Convertible Preferred stock
12:00am
DEFA14A
9uab3rjdz792 n7b
28 Aug 14
Additional proxy soliciting materials
12:00am
8-K
px0hwx14naa1v8wfhq6
14 Jul 14
Peregrine Pharmaceuticals Reports fourth Quarter and year-end Fiscal Year 2014 Financial Results and Recent Developments
12:00am
8-K
rzb7aainn xdeek
16 Jun 14
Entry into a Material Definitive Agreement
12:00am
424B5
ne383dsp
13 Jun 14
Prospectus supplement for primary offering
12:00am
424B5
ou2xds5gacm
13 Jun 14
Prospectus supplement for primary offering
12:00am
8-K
h065z97f tj
10 Jun 14
Peregrine PHARMACEUTICALS DECLARES QUARTERLY DIVIDEND on ITS Series E Convertible Preferred stock
12:00am
8-K
owb53xmr998ic9u 4lm
8 May 14
Departure of Directors or Certain Officers
12:00am
8-K
eyamwrd c1utepdzc6
5 May 14
Other Events
12:00am
8-K
lko5ioe 72
11 Mar 14
Peregrine PHARMACEUTICALS DECLARES QUARTERLY DIVIDEND on ITS Series E Convertible Preferred stock
12:00am
8-K
da7dxs x9849
7 Mar 14
Peregrine Pharmaceuticals Reports THIRD Quarter Fiscal Year 2014 Financial Results and Recent Developments
12:00am